Dynabeads™ M-270 Epoxy
Dynabeads™ M-270 Epoxy
Invitrogen™

Dynabeads™ M-270 Epoxy

Dynabeads™ M-270エポキシビーズは、表面エポキシ基を含む2.8 µmの超常磁性ビーズです。このビーズはタンパク質やペプチド中の一次アミノ基およびスルフヒドリル基と共有結合するため、抗体、ペプチド、インタクトタンパク質、および機能酵素の結合に最適です。これらの親水性の中性pHビーズは詳細を見る
製品番号(カタログ番号)数量
1430160 mg
14302D300 mg
製品番号(カタログ番号) 14301
価格(JPY)
-
見積もりを依頼する
数量:
60 mg
Dynabeads™ M-270エポキシビーズは、表面エポキシ基を含む2.8 µmの超常磁性ビーズです。このビーズはタンパク質やペプチド中の一次アミノ基およびスルフヒドリル基と共有結合するため、抗体、ペプチド、インタクトタンパク質、および機能酵素の結合に最適です。これらの親水性の中性pHビーズは、タンパク質や色素の非特異的結合がきわめて低く、ブロッキング剤の必要性を低減します。また、Dynabeads™ M-270エポキシビーズにはTween™界面活性剤が含まれていないため、質量分析(MS)に最適です。

•タンパク質およびタンパク質複合体の免疫沈降(IP)に最適
• 穏やかでありながら迅速な磁気分離と短いインキュベーション時間により、一過性および不安定な複合体を同定可能
• 抗体がDynabeads™と共有結合することで、標的タンパク質との抗体の共溶出を回避

さまざまなアプリケーションに適応可能
高速表面結合カイネティクスおよび迅速な磁気分離特性により、Dynabeads™ M-270エポキシビーズは、タンパク質やタンパク質複合体の免疫沈降/精製、下流アッセイ用のビーズ表面への機能酵素の結合、タンパク質結合パートナーの特定などのアプリケーションに最適な選択肢となります。DynaMag™マグネットとDynabeads™の磁気分離特性により、捕捉されたタンパク質およびタンパク質複合体は簡単に分離、洗浄、溶出できます。

結合手順
目的のリガンド(一般的に抗体、ペプチド、またはタンパク質)をDynabeads™ M-270エポキシビーズでインキュベートすることにより、一晩で共有結合を行います。結合能は使用するリガンドによって異なりますが、通常、1ミリグラムのビーズあたり5~10 µgのIgGです。結合は中性pHおよび高塩濃度で発生します。結合反応は、リガンドの安定性特性に合わせて幅広い温度範囲で実行できます。

リガンド結合ステップが完了すると、Dynabeads™ M-270エポキシビーズの反応基が非活性化され、それ以上の結合が防止されます。結合反応が完了すると、これらのノンポーラス、親水性のpH中性ビーズは非特異的結合がきわめて低くなります。

Dynabeads™製品の詳細
幅広いアプリケーションに対応する Dynabeads™製品をご覧ください。
• Dynabeads™分離用マグネットをご確認ください。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
直径(メートル法)2.8 μm
最小溶出量5 μL
フォーマット凍結乾燥
純度または品質グレード研究グレード
数量60 mg
サンプルタイプあらゆるサンプルタイプ
品質保持期間製造日から24ヶ月
出荷条件室温
表面機能エポキシ
製品ラインDYNAL、Dynabeads
タイプエポキシビーズ
Unit SizeEach
組成および保存条件
60 mg Dynabeads™ M-270 Epoxy、約6.7 × 107ビーズ/mg入り。凍結乾燥粉末として提供。

2℃~8℃で保管してください。

よくあるご質問(FAQ)

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

引用および参考文献 (2)

引用および参考文献
Abstract
AFFIRM--a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis.
Authors:Säll A, Carlsson F, Olsson N, Wingren C, Ohlin M, Persson H, Waldemarson S
Journal:
PubMed ID:25337893
Targeted measurements of low abundance proteins in complex mixtures are in high demand in many areas, not the least in clinical applications measuring biomarkers. We here present the novel platform AFFIRM (AFFInity sRM) that utilizes the power of antibody fragments (scFv) to efficiently enrich for target proteins from a complex ... More
A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood.
Authors:Cartwright M, Rottman M, Shapiro NI, Seiler B, Lombardo P, Gamini N, Tomolonis J, Watters AL, Waterhouse A, Leslie D, Bolgen D, Graveline A, Kang JH, Didar T, Dimitrakakis N, Cartwright D, Super M, Ingber DE
Journal:EBioMedicine
PubMed ID:27333027
Blood cultures, and molecular diagnostic tests that directly detect pathogen DNA in blood, fail to detect bloodstream infections in most infected patients. Thus, there is a need for a rapid test that can diagnose the presence of infection to triage patients, guide therapy, and decrease the incidence of sepsis. ... More